Loading...
Loading...
India accounts for a significant share of global Liraglutide exports, with 53+ registered manufacturers shipping to buyers across 36+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 52.6% (export value: $2.3M). Close behind, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI (43.9%, $1.9M). LUPIN LIMITED (0.8%, $35.4K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Liraglutide from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Liraglutide export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 52.6% share, shipping $2.3M worth of product across 15 shipments. The second-largest exporter, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, contributes $1.9M (43.9%) to the overall market. Combined, the top two suppliers alone account for 96.5% of all Liraglutide exports, indicating a relatively concentrated supply base.
Across all 53 tracked manufacturers, the total Liraglutide export value stands at $4.3M from 416 shipments. The market average shipment value is $10.3K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM, receiving $2.3M worth of product.
The combined buyer network spans 20 named purchasing companies, including YUSEN LOGISTICS BENELUX BELGIUM, NOVOCHEMIX BIOMEDIC , SUN PHARMA EAST AFRI, ALKALOIDA CHEMICAL C, M/S MEDPRO PHARMACEUTICA PTY LTD and 15 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Liraglutide exporter from India, with a market share of 52.6% and a total export value of $2.3M across 15 shipments. Their average shipment value of $150.0K is above the market average of $10.3K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $2.3M across 15 shipments (100.0% of this supplier's total exports)
• NOVOCHEMIX BIOMEDIC — $60 across 0 shipments (0.0% of this supplier's total exports)
• SUN PHARMA EAST AFRI — $9 across 0 shipments (0.0% of this supplier's total exports)
• ALKALOIDA CHEMICAL C — $8 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $150.0K is 1359% above the market average of $10.3K, consistent with large-order contracts or value-added formulations.
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI is the second-largest Liraglutide exporter from India, with a market share of and a total export value of across . Their average shipment value of is
Once Liraglutide leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, it travels to 5 destination markets with a combined import value of $4.3M. Belgium absorbs the largest share at 52.7% ($2.3M), followed by South Africa (32.6%) and Hong Kong (7.6%).
In Belgium — the top destination — named importers include YUSEN LOGISTICS BENELUX BELGIUM. In South Africa, key buyers are M/S MEDPRO PHARMACEUTICA PTY LTD.
This geographic spread reflects Liraglutide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Liraglutide exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
Belgium ranks as the first-largest destination for Liraglutide imports from India, with a total trade value of $2.3M across 7 shipments — representing a 52.7% share of all Liraglutide exports. The average shipment value of $321.9K is above the global average of $10.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Liraglutide importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 99.9% ($2.3M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $2.3M (99.9% of Belgium's total)
Key Insight: Belgium's per-shipment average of $321.9K (3030% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Liraglutide imports from India.
South Africa ranks as the second-largest destination for Liraglutide imports from India, with a total trade value of across — representing a share of all Liraglutide exports. The average shipment value of is
Latest developments and market context
Detailed market intelligence for Liraglutide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI serves 5 named buyers in our database. M/S MEDPRO PHARMACEUTICA PTY LTD is the dominant customer, accounting for 74.3% of this supplier's tracked business. Top customers include:
• M/S MEDPRO PHARMACEUTICA PTY LTD — $1.4M across 68 shipments (74.3% of this supplier's total exports)
• SUCCEED HOLDINGS LTD. — $324.7K across 16 shipments (17.3% of this supplier's total exports)
• M/S BOSTON ONCOLOGY — $152.5K across 7 shipments (8.1% of this supplier's total exports)
• CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED — $5.0K across 0 shipments (0.3% of this supplier's total exports)
• CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED — $131 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI's per-shipment value of $20.6K is 101% above the market average of $10.3K, consistent with large-order contracts or value-added formulations.
LUPIN LIMITED is the third-largest Liraglutide exporter from India, with a market share of 0.8% and a total export value of $35.4K across 10 shipments. Their average shipment value of $3.5K is below the market average of $10.3K, reflecting a high-volume, competitive pricing strategy.
LUPIN LIMITED serves 5 named buyers in our database. DR,ANTHONY ANDRE, is the dominant customer, accounting for 78.1% of this supplier's tracked business. Top customers include:
• DR,ANTHONY ANDRE, — $27.6K across 8 shipments (78.1% of this supplier's total exports)
• XXOIMXXNE XXD — $3.9K across 1 shipments (10.9% of this supplier's total exports)
• PROIMMUNE LIMITED — $3.9K across 1 shipments (10.9% of this supplier's total exports)
• MS SOFIE PATTYN IMMU — $24 across 0 shipments (0.1% of this supplier's total exports)
• IMMUNXPERTS SA RUE C — $24 across 0 shipments (0.1% of this supplier's total exports)
Key Insight: LUPIN LIMITED operates with high shipment frequency (10 shipments) at a per-shipment value of $3.5K, indicating a broad distribution network with many smaller, regular orders.
ABBOTT INDIA LIMITED is the fourth-largest Liraglutide exporter from India, with a market share of 0.3% and a total export value of $14.3K across 5 shipments. Their average shipment value of $2.9K is below the market average of $10.3K, reflecting a high-volume, competitive pricing strategy.
ABBOTT INDIA LIMITED serves 2 named buyers in our database. PHARMACHEM PRIVATE is the dominant customer, accounting for 52.6% of this supplier's tracked business. Top customers include:
• PHARMACHEM PRIVATE — $7.5K across 3 shipments (52.6% of this supplier's total exports)
• PHARMACHEM PRIVATE — $6.8K across 2 shipments (47.4% of this supplier's total exports)
Key Insight: ABBOTT INDIA LIMITED operates with high shipment frequency (5 shipments) at a per-shipment value of $2.9K, indicating a broad distribution network with many smaller, regular orders.
ONESOURCE SPECIALTY PHARMA LIMITED is the fifth-largest Liraglutide exporter from India, with a market share of 0.3% and a total export value of $11.7K across 17 shipments. Their average shipment value of $688 is below the market average of $10.3K, reflecting a high-volume, competitive pricing strategy.
ONESOURCE SPECIALTY PHARMA LIMITED serves 5 named buyers in our database. CHEMO LABORATORIOS LICONSA, S.A is the dominant customer, accounting for 90.3% of this supplier's tracked business. Top customers include:
• CHEMO LABORATORIOS LICONSA, S.A — $10.6K across 15 shipments (90.3% of this supplier's total exports)
• NUOVA OMPI S.R.L UNI — $679 across 1 shipments (5.8% of this supplier's total exports)
• MERIEUX NUTRISCIENCE — $431 across 1 shipments (3.7% of this supplier's total exports)
• GALENICUM HEALTH S.L — $19 across 0 shipments (0.2% of this supplier's total exports)
• TRIUMPHARMA LLC — $9 across 0 shipments (0.1% of this supplier's total exports)
Key Insight: ONESOURCE SPECIALTY PHARMA LIMITED operates with high shipment frequency (17 shipments) at a per-shipment value of $688, indicating a broad distribution network with many smaller, regular orders.
REGALIA LIFE SCIENCE PRIVATE LIMITED is the fifth-largest Liraglutide exporter from India, with a market share of 0.2% and a total export value of $8.1K across 6 shipments. Their average shipment value of $1.3K is below the market average of $10.3K, reflecting a high-volume, competitive pricing strategy.
REGALIA LIFE SCIENCE PRIVATE LIMITED serves 1 named buyer in our database. PURCHASE MANAGER is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PURCHASE MANAGER — $8.1K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: REGALIA LIFE SCIENCE PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $1.3K, indicating a broad distribution network with many smaller, regular orders.
Named Liraglutide importers in South Africa: M/S MEDPRO PHARMACEUTICA PTY LTD is the largest buyer, accounting for 100.0% ($1.4M) of this market's total imports.
• M/S MEDPRO PHARMACEUTICA PTY LTD — $1.4M (100.0% of South Africa's total)
Key Insight: South Africa's per-shipment average of $465.2K (4424% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Liraglutide imports from India.
Hong Kong ranks as the third-largest destination for Liraglutide imports from India, with a total trade value of $324.7K across 2 shipments — representing a 7.6% share of all Liraglutide exports. The average shipment value of $162.3K is above the global average of $10.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Liraglutide importers in Hong Kong: SUCCEED HOLDINGS LTD. is the largest buyer, accounting for 100.0% ($324.7K) of this market's total imports.
• SUCCEED HOLDINGS LTD. — $324.7K (100.0% of Hong Kong's total)
Key Insight: Hong Kong's per-shipment average of $162.3K (1479% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Hong Kong is a key market for Liraglutide imports from India.
Saudi Arabia ranks as the fourth-largest destination for Liraglutide imports from India, with a total trade value of $152.5K across 0 shipments — representing a 3.6% share of all Liraglutide exports. The average shipment value of $152.5K is above the global average of $10.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Saudi Arabia's per-shipment average of $152.5K (1383% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Liraglutide imports from India.
United States ranks as the fifth-largest destination for Liraglutide imports from India, with a total trade value of $31.3K across 2 shipments — representing a 0.7% share of all Liraglutide exports. The average shipment value of $15.6K is above the global average of $10.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Liraglutide importers in United States: DR,ANTHONY ANDRE, is the largest buyer, accounting for 88.3% ($27.6K) of this market's total imports.
• DR,ANTHONY ANDRE, — $27.6K (88.3% of United States's total)
Key Insight: United States's per-shipment average of $15.6K (52% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Liraglutide imports from India.
Top supplier: 4 customers
6 suppliers → 36 countries
Network value: $4.3M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
416 Verified Shipments
53 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists